Details of the Drug

General Information of Drug (ID: DMWQ38D)

Drug Name

Milatuzumab-doxorubicin conjugate

Indication

Disease Entry	ICD 11	Status	REF
Multiple myeloma	2A83	Phase 1/2	[1]
------------------------------------------------------------------------------------

Drug Type

Antibody drug conjugate

Cross-matching ID

References

1	ClinicalTrials.gov (NCT01101594) A Study of hLL1-DOX (Milatuzumab-Doxorubicin Antibody-Drug Conjugate) in Patients With Multiple Myeloma. U.S. National Institutes of Health.